|
 |
| EMEDEAS |
|
EMEDEASTM Early Medical Device Assessment
Based on state-of the art systems analysis methods and risk assessment tools, we incorporate clinical, technical, and market components into an integrated assessment and management tool. This allows us to develop jointly with our clients a comprehensive understanding of the most important drivers of patient benefit and product success.
Using our EMEDEAS™ framework, our clients are able to
• identify the factors that are most critical to product success
• pinpoint and quantify uncertainties in various aspects of the technology and its application, and manage them accordingly
• perform scenario analyses and inform decision making at various stages of product development
|
|
|
|
|
 |
|
Our clients have used our analyses to support the following decisions:
• Concept due diligence
• Early-stage opportunity assessment
• Investment decisions
• Priority-setting for resource allocation
• Development and updating of product development plan
• Go- No-Go decisions
• Strategy development for targeted engineering, clinical, and market research
• Regulatory and reimbursement strategy
• Clinical trial formulation
• Product launch strategy
• Development of licensing terms
• Product pricing (health-economics/ cost-benefit)
• Portfolio management
|
|
|
|
| |
Sample applications of the EMEDEAS framework have included:
• Musculoskeletal: New technology for hip joint replacement surgery
• Gastrointestinal: Evaluation and decision support for new optical screening technology
• Sleep Medicine: Strategy development for Obstructive Sleep Apnea (OSA) screening and therapy |
|
|
|
|
|
|
|
 |
| | SPOTLIGHT | | | Feb. 2010: Ardian Inc. retains Wing Tech to develop comprehensive health-economic model for it's Symplicity® Catheter System™. Ardian is a leading venture-funded medtech company developing a novel catheter-based treatment for hypertension.
Read More |
| | | SPOTLIGHT | | | Jan. 29, 2010: BME Seminar presentation by Jan Pietzsch at NU Chicago: "Thinking ahead - Value-based assessment of medical technology innovations in an era of health-care reform"
Read More |
| | | SPOTLIGHT | | | Oct. 15, 2009: World Health Summit Berlin - Wing Tech participates in Panel Discussion "How to Reimburse Innovations in Regenerative Medicine"
Read More |
| | | SPOTLIGHT | | | June 29, 2009: Best-practice model on medical device development published - Effort to support successful execution of bench-to-bedside process of technology commercialization
Read More |
| | | SPOTLIGHT | | | Apr. 7, 2009 "Effective Medical Device and Diagnostics Development" session at Medtec Japan in Yokohama chaired by Wing Tech Inc.
Read More |
| | | SPOTLIGHT | | | April 3, 2009: Stanford University Course "Technology Assessment and Regulation of Medical Devices" given Spring Quarter 2009 by Jan B. Pietzsch
Read More |
| | | SPOTLIGHT | | | Dec. 2008: Wing Tech Inc./ Wingtec GmbH provide risk management tools to BCRT to efficiently advance novel therapeutic concepts from R&D into the clinic.
Read More |
| | | SPOTLIGHT | | | Oct. 2008: Wing Tech Inc. participates in Northwestern University study assessing impact of technology in diagnosis and treatment of sleep apnea
Read More |
| | | SPOTLIGHT | | | May 2008 Workshop "Challenges for Translating T-Cell Therapy from Bench to Bedside" at Charité Berlin with Wing Tech participation.
Read More |
| | | SPOTLIGHT | | | "A Road Map for Device and Diagnostic Innovation:
Opportunities for Industry and Regulators," April 30, 2008 Washington D.C., with Wing Tech participation.
Read More |
| | | SPOTLIGHT | | | Jan Pietzsch to speak at World Leaders in Medical Innovations Conference on April 23, 2008 in London (UK) -- Global trends in the medical device industry
Read More |
| | | SPOTLIGHT | | | Wing Tech particiaptes in Stanford InHealth Research study on "Medical Device Development Models"
Read More |
| | | SPOTLIGHT | | | Independent Panel of Guidant Corporation cites Early Tech Assessment Work by Wing Tech Inc. Executive and Advisors
Read More |
|
 |
|
